Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Ghiringhelli

Showing results (11-20 of 95) with videos related to

Pageof 10
Sort By:
World Journal of Gastroenterology|September 15, 2009
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot studyFrancois Ghiringhelli, Boris Guiu, Bruno Chauffert, et al.
World Journal of Gastrointestinal Oncology|April 19, 2018
<i>EGFR</i> amplification induces sensitivity to anti<i>EGFR</i> therapy in pancreatic acinar cell carcinomaCorentin Richard, Julie Niogret, Romain Boidot, et al.
Cell Stress|June 22, 2019
Regulation of T cell antitumor immune response by tumor induced metabolic stressFanny Chalmin, Mélanie Bruchard, Frederique Vegran, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agentsFrancois Ghiringhelli, Cedric Rebe, Aziz Hichami, et al.
British Journal of Cancer|March 23, 2019
Cell lines and immune classification of glioblastoma define patient's prognosisQuentin Klopfenstein, Caroline Truntzer, Julie Vincent, et al.
Immunological Reviews|November 15, 2006
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progressionFrancois Ghiringhelli, Cédric Ménard, Francois Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2020
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging conceptsJean-David Fumet, Caroline Truntzer, Mark Yarchoan, et al.
Cancers|September 19, 2020
Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of ChemotherapyJean-David Fumet, Emeric Limagne, Marion Thibaudin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancerCaroline Truntzer, Nicolas Isambert, Laurent Arnould, et al.
International Journal of Colorectal Disease|November 13, 2015
HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case reportRomain Boidot, Sandy Chevrier, Vincent Julie, et al.
Pageof 10

Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
World Journal of Gastroenterology|September 15, 2009
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot studyFrancois Ghiringhelli, Boris Guiu, Bruno Chauffert, et al.
World Journal of Gastrointestinal Oncology|April 19, 2018
<i>EGFR</i> amplification induces sensitivity to anti<i>EGFR</i> therapy in pancreatic acinar cell carcinomaCorentin Richard, Julie Niogret, Romain Boidot, et al.
Cell Stress|June 22, 2019
Regulation of T cell antitumor immune response by tumor induced metabolic stressFanny Chalmin, Mélanie Bruchard, Frederique Vegran, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agentsFrancois Ghiringhelli, Cedric Rebe, Aziz Hichami, et al.
British Journal of Cancer|March 23, 2019
Cell lines and immune classification of glioblastoma define patient's prognosisQuentin Klopfenstein, Caroline Truntzer, Julie Vincent, et al.
Immunological Reviews|November 15, 2006
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progressionFrancois Ghiringhelli, Cédric Ménard, Francois Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2020
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging conceptsJean-David Fumet, Caroline Truntzer, Mark Yarchoan, et al.
Cancers|September 19, 2020
Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of ChemotherapyJean-David Fumet, Emeric Limagne, Marion Thibaudin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancerCaroline Truntzer, Nicolas Isambert, Laurent Arnould, et al.
International Journal of Colorectal Disease|November 13, 2015
HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case reportRomain Boidot, Sandy Chevrier, Vincent Julie, et al.
Pageof 10